Kulikov A V, Avgustinovich D F, Kolpakov V G, Maslova G B, Popova N K
Institute of Cytology & Genetics, Russian Academy of Sciences, Siberian Branch, Novosibirsk.
Pharmacol Biochem Behav. 1995 Mar;50(3):383-7. doi: 10.1016/0091-3057(94)00280-v.
Specific binding of [3H]ketanserin to 5-HT2A serotonin receptor sites in the corpus striatum and frontal cortex and the effect of 5-HT2A antagonists in rats and mice hereditarily predisposed to catalepsy has been studied. Cyproheptadine inhibited the expression of inherited catalepsy in rats and mice, whereas more selective 5-HT2A antagonists, ritanserin and ketanserin, failed to affect the catalepsy. A decrease in [3H]ketanserin-specific binding site density in the striatum of cataleptic animals compared to their noncataleptic counterparts was found. It was suggested that the decrease in the density of 5-HT2A receptor binding sites in the striatum represents a result of their downregulation due to increased serotonergic neurotransmission in the striatum of cataleptic animals.